Trial Profile
Randomized, double-blind, place-controlled study of donepezil in post-stroke patients with chronic non-fluent aphasia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Aphasia
- Focus Therapeutic Use
- 09 Apr 2011 New trial record